Your Article Summary
See Latest ArticlesConducting biodefense-related research in a highly regulated academic environment
Drug Development Research, 06/19/09
Chopra AK et al. - Most of these regulations were created and are enforced to control access to a limited number of microbial agents considered to be the greatest threat to civilians and military personnel. While most scientists understand the need for some control, the extent of recent restrictions is seen by some as an almost insurmountable barrier to effective research, and perhaps as tantamount to a breach of academic freedom.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
MabThera/Rituxan is the first treatment to show improved overall survival in previously untreated patients with chronic lymphocytic leukemia
Roche, 12/09/09
Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation
PhRMA, 12/09/09
Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines
Cell Therapeutics, 12/08/09